Tien Liang BioTech Co., Ltd. (TPEX:4127)

Market Cap	1.68B
Revenue (ttm)	383.94M
Net Income (ttm)	21.76M
Shares Out	45.76M
EPS (ttm)	0.48
PE Ratio	77.06
Forward PE	n/a
Dividend	0.50 (1.36%)
Ex-Dividend Date	n/a

Volume	68,015
Average Volume	50,559
Open	36.65
Previous Close	36.65
Day's Range	36.40 - 36.75
52-Week Range	27.05 - 44.00
Beta	0.29
RSI	46.67
Earnings Date	Aug 12, 2025

About Tien Liang BioTech

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete’s foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, h...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 61
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4127

Financial Performance

In 2024, Tien Liang BioTech's revenue was 385.21 million, a decrease of -16.26% compared to the previous year's 459.99 million. Earnings were 11.70 million, a decrease of -34.04%.